Barclays PLC Makes New $385,000 Investment in Ardent Health Partners, LLC (NYSE:ARDT)

Barclays PLC bought a new stake in Ardent Health Partners, LLC (NYSE:ARDT) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 20,992 shares of the company’s stock, valued at approximately $385,000.

Several other institutional investors also recently modified their holdings of the business. Seven Grand Managers LLC bought a new position in shares of Ardent Health Partners in the 3rd quarter worth $2,298,000. Allspring Global Investments Holdings LLC bought a new position in Ardent Health Partners during the third quarter worth about $13,119,000. Financial Management Professionals Inc. bought a new position in Ardent Health Partners during the third quarter worth about $50,000. Charles Schwab Investment Management Inc. acquired a new position in shares of Ardent Health Partners during the 3rd quarter worth about $526,000. Finally, BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $42,000.

Ardent Health Partners Stock Down 1.2 %

NYSE:ARDT opened at $16.64 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a twelve month low of $14.57 and a twelve month high of $20.72. The business’s 50 day moving average price is $16.75.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. KeyCorp started coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective for the company. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Leerink Partners lifted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, November 12th. Stephens reaffirmed an “overweight” rating and set a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners currently has an average rating of “Buy” and an average price target of $22.00.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.